Red cell-mediated therapy: Opportunities and challenges

Blood Cells, Molecules and Diseases

Volumn 23, Issue 1, 1997, Pages 58-68

  Krantz, Allen ^a  

^a Red Cell Inc   (United States)

Author keywords

Affinity labels; Anchors; Bonding; Combinatorial libraries; Covalent labeling

Indexed keywords

DRUG CARRIER; ERYTHROCYTE BAND 4.1 PROTEIN;

BINDING AFFINITY; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; PRIORITY JOURNAL; REVIEW;

EID: 0030878357     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1997.0119     Document Type: Article

References (26)

1. Hillman R S, Rinch C A. Red Cell Manual. 1992;F.A. Davis Company, Philadelphia.
2. Deloach J R, Way J L. Carrier and Bioreactor Red Blood Cells for Drug Delivery and Targeting. 1994;Elsevier, Tarrytown.
3. M, Magnani, J, R, DeLoach, The Use of Resealed Erythrocytes as Carriers and Bioreactors, Plenum Press, New York.
4. P, Pouletty, C, Pouletty.
5. Wilchek M, Bayer E A. The avidin-biotin complex in bioanalytical applications. Anal Biochem. 171:1988;1-32.
6. i. Biochemistry. 30:1991;8165-8170.
7. Jakoby W B, Wilchek M. Methods in Enzymology. 1977;Academic Press, New York.
8. Schrier S L. Red cell membrane biology-an introduction. Clin Haematol. 14:1985;1-12.
9. Chasis J A, Mohandas N. Red blood cell glycophorins. Blood. 80:1992;1869-1879.
10. Rahuel C, London J, Vignal A. Alteration of the genes for glycophorin A and B in glycophorin-A-deficient individuals. Eur J Biochem. 177:1988;605.
11. Tomita M, Furthmayr H, Marchesi V T. Primary structure of human erythrocyte glycophorin-A. Isolation and characterization of peptides and complete amino acid sequence. Biochemistry. 17:1978;4756-4770.
12. Chasis J A, Reid M E, Jensen R H, Mohandes N. Signal transduction by glycophorin A: role of extracellular and cytoplasmic domains in a modulatable process. J Cell Biol. 107:1988;1351-1357.
13. Abelson J N. Methods in Enzymology. 1996;Academic Press, New York.
14. Powell M F. Peptide Stability in Drug Development:In Vitro. Ann Rep Med Chem. 28:1995;285.
15. Greenlee W J. Renin Inhibitors. Med Res Rev. 10:1990;173-236.
16. Suzuki T, Dale G L. Biotinylated Erythrocytes:In VivoIn vitro. Blood. 70:1987;791-795.
17. Christian J A, Rebar A H, Boon G D, Low P S. Methodological considerations for the use of caninein vivo. Exp Hematol. 24:1996;82-88.
18. Samokhin G P, Smirnov M D, Muzykantov V, Domogatsky S, Smirnov V. Red blood cell targeting to collagen-coated surfaces. FEBS Letters. 154:1983;257-261.
19. Bertram G, Katzung M D. Basic and Clinical Pharmacology. 1995;Appleton and Lange, Norwalk.
20. Houck K S, Huang L. The role of multivalency in antibody mediated liposome targeting. Biochem Biophys Res Commun. 145:1987;1205-1210.
21. Coller B S, Springer K T, Beer J H. Thromboerythrocytes.In vitro. J Clin Invest. 89:1992;546-555.
22. Chatterjee R, Iwai Y, Walder R Y, Walder J A. Structural features required for the reactivity and intracellular transport of bis(3,5-dibromosalicyl)fumarate and related anti-sickling compounds that modify hemoglobin S at the 2,3-diphosphoglycerate binding site. J Biol Chem. 259:1984;14863-14873.
23. Smirnov V N, Domogatsky S P, Dolgov V V. Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall. Proc Natl Acad Sci USA. 83:1986;6603-6607.
24. Muzykantov V R, Sakharov D V, Smirnov M D, Samokhin G P, Smirnov V N. Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clot. Biochim Biophys Acta. 884:1986;355-362.
25. P, Pouletty, D, Blanchard.
26. C, Nicolau, Y, Mouneimne, P-F, Tosi, 1993, Anal Biochem, 214, 1, 10.